Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
St. Jude Hospital announces availability of largest collections of leukemia samples

St. Jude Hospital announces availability of largest collections of leukemia samples

Researchers unravel mystery of NPM1 protein in acute myeloid leukemia

Researchers unravel mystery of NPM1 protein in acute myeloid leukemia

Cancer stem cells depend on amino acid metabolism, and it's proving to be their Achilles' heel

Cancer stem cells depend on amino acid metabolism, and it's proving to be their Achilles' heel

New study sheds light on how CAR T cell therapy works

New study sheds light on how CAR T cell therapy works

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Mutant p53 protein 'tackles' DNA guardian to drive tumor development

Researchers develop first chemical inhibitors for treatment of acute myeloid leukemia

Researchers develop first chemical inhibitors for treatment of acute myeloid leukemia

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

TGen and City of Hope announce letter of intent to develop new cell therapy manufacturing facility

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

PPM1D gene confers a survival advantage to stem cells after chemotherapy

PPM1D gene confers a survival advantage to stem cells after chemotherapy

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

Measles can be deadly for people with weakened immune systems

Measles can be deadly for people with weakened immune systems

MCG selected as designated laboratory for NCI-MATCH trial

MCG selected as designated laboratory for NCI-MATCH trial

UCLA researchers investigate how a protein factor contributes to cancer cell migration

UCLA researchers investigate how a protein factor contributes to cancer cell migration

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Study shows how machinery within immune system activates T cells to attack cancer

Study shows how machinery within immune system activates T cells to attack cancer

Barcelona researchers win one of the most prestigious EU grants to study CLL

Barcelona researchers win one of the most prestigious EU grants to study CLL

Head and neck cancer survivors more likely to commit suicide

Head and neck cancer survivors more likely to commit suicide

Scientists identify new target for battling deadly form of leukemia

Scientists identify new target for battling deadly form of leukemia